Sitemap
February 24, 2020 Articles
Filter by Available Specialty
- ‘Opening the discussion’: Complementary therapy in IBD
- A Phase I Clinical Trial of T Cells Expressing a Novel Fully Human Anti-BCMA CAR for Treating Multiple Myeloma
- A Safety and Efficacy Study Evaluating CTX120 in Subjects with Relapsed or Refractory Multiple Myeloma
- Acid suppression linked with multidrug-resistant microorganism colonization
- ACR releases first ever guideline on reproductive health in rheumatic disease
- Alert-based interventions reduce C. difficile testing, infection rates
- Are e-cigarettes a viable tool to help patients with cancer quit smoking?
- Autologous CD8+ T cells Expressing an Anti-BCMA CAR in Patients with Myeloma
- BCMA-Specific CAR T Cells Combined with a Gamma Secretase Inhibitor (JSMD194) to Treat Relapsed or Persistent Multiple Myeloma
- Behavioral therapy plus medication delivered in primary care proves successful for weight loss
- Beta-cell dysfunction typifies type 2 diabetes without obesity
- BIOFLOW V: SES reduces event rates at 3 years vs. EES
- DDIs affect around 40% of HCV patients taking DAAs
- De-escalation chemotherapy after negative PET scan appears safe in low-volume metastatic seminoma
- Dementia rates set to double in Europe by 2050, echoing US estimates
- Endovascular treatment with standard care improved outcomes for basilar artery occlusion
- Enrollment complete in Cambium dry eye study
- Exchanging multifocal IOL optic design proves successful in study
- Expert Panel Document Guides CAR-T Use for Advanced B-Cell Lymphoma
- FDA approves Vyepti, first IV preventive treatment for migraine
- FDA grants dulaglutide CV indication for diabetes with or without established CVD
- FDA grants priority review to brigatinib for first-line treatment of ALK-positive lung cancer
- Few adolescents with HIV achieve viral suppression within 5 months
- First-In-Human Study of REGN5459 in Patients With Relapsed or Refractory Multiple Myeloma
- Fundus photography may help differentiate TIA, stroke from mimic
- Individualized treatment rule improves treatment success rate of first-episode schizophrenia
- Journal retracts paper on MI risk with e-cigarette use, gut microbial metabolite tied to CHD — top stories in cardiology
- Multiple myeloma: The next frontier for cell therapy
- Natural Killer Cells Plus Immunotherapy for Triple-Negative Breast Cancer
- Opioid series highlights new protocols to reduce opioid use
- Patient-reported flares in RA linked to inflammation found via MRI, ultrasound
- Potentially harmful ‘prescribing cascade’ common in older adults with hypertension
- Promoting APP professionalism in hematopoietic stem cell transplantation
- Real-world study shows benefits in switching to preservative-free fixed-dose combination glaucoma therapy
- Recovery, length of stay correlated with mobility, self-care outcomes after hip fracture surgery
- Remote treatment monitoring for peritoneal dialysis lowers hospitalization, technique failure rates
- Rituximab shows promise in refractory lupus erythematosus panniculitis in children
- Smoking cessation should be ‘pillar’ of the cancer treatment protocol
- Standardized measures of visual disturbance needed to inform IOL choice
- Study shows opportunities to reduce contact lens wear dropout
- Subsequent PFS benefit of apalutamide ‘an indicator of effective early intensive treatment’ in prostate cancer
- The administration beats cancer
- Upfront CART-BCMA with or without huCART19 in High-risk Multiple Myeloma
- VIDEO: Recent updates in Crohn’s disease
- Withholding pre-hydration before contrast-enhanced CT seen as safe for patients with CKD